Aims There are few studies of the use of intra-aortic balloon pump (IABP) treatment as a bridge to heart transplantation (HTx). This is the first study to compare long-term clinical and haemodynamic ...
MUNICH and WAYNE, N.J., Aug. 27, 2012 /PRNewswire/ -- MAQUET Cardiovascular LLC, the market leader in intra-aortic balloon counterpulsation therapy, today announced 30-day results from the large, ...
Intra-aortic balloon pump counterpulsation prior to PCI in patients with ST segment elevation MI does not reduce infarct size as measured by MRI, according to results from the Counterpulsation Reduces ...
Please provide your email address to receive an email when new articles are posted on . A routine strategy of intra-aortic balloon counterpulsation before percutaneous coronary intervention did not ...
Dr. Cohen, together with Dr. Gautam Visveswaran, Dr. David Baran and colleagues at Newark Beth Israel Medical Center, retrospectively analyzed demographic, clinical, laboratory and hemodynamic ...
Please provide your email address to receive an email when new articles are posted on . Infarct size as measured by MRI does not reduce when intra-aortic balloon pump counterpulsation is used before ...
Inserting intra-aortic balloon pumps prior to angioplasty in patients with acute myocardial infarction does not reduce the scope of heart muscle damage, a condition referred to as infarct size, ...
Intra-aortic balloon pump counterpulsation prior to PCI in patients with ST segment elevation MI does not reduce infarct size as measured by MRI, according to results from the Counterpulsation Reduces ...
MUNICH, Germany—Although use of an intra-aortic balloon pump (IABP) in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock appears safe, the technique does not improve ...
ANGIODROID Srl, an Italian manufacturer of medical technologies, announces the CE mark for ANGIOPULSE, its first intra-aortic balloon pump (IABP) device. (Photo ...
This study demonstrates that IABP is a valuable tool as a bridge to HTx in patients with end-stage heart failure. Kaplan–Meier analysis revealed no significant difference in post-HTx survival between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results